Ultimately, the decision to use GLP-1 medications should be made in partnership with healthcare providers who understand both your health goals and financial situation
No labs, medical consultation, or app-based coaching is included
The results of the ATTAIN-MAINTAIN trial, published May 12 in Nature Medicine, showed that switching to the once-daily orforglipron pill may address this need and help maintain the cardiometabolic benefits
Key mechanisms include: Enhanced Glucose-Dependent Insulin Secretion: GLP-1 receptor stimulation amplifies insulin release only in the presence of glucose, minimizing hypoglycemia risk
This matters most if you use diabetes meds, blood pressure meds, blood thinners, transplant meds, or drugs with narrow safety margins